multi source·15h ago·3 sources analyzed
Sun Pharma to acquire Organon in $11.75 billion deal
Sun Pharmaceutical Industries will purchase Organon & Co in an all-cash transaction. This acquisition aims to enhance Sun Pharma's global presence. (sources: cnbc, wsj, reuters)
ModernAction Briefing
Sun Pharma will acquire Organon for $11.75 billion, marking a significant move in the pharmaceutical sector. The deal is expected to strengthen Sun Pharma's position in the global market.
- The acquisition is valued at $11.75 billion and will be conducted in cash.
- Organon is based in New Jersey and operates in the healthcare sector.
- Sun Pharma's shares increased by 7% following the announcement of the deal.
Why it matters
This acquisition reflects ongoing consolidation in the pharmaceutical industry and may impact market dynamics.
No specific legislation identified for action yet.